Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
29 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsNovartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
(WorldNews Switzerland)

 
 

25 february 2020 08:38:33

 
Novartis and DNDi to collaborate on the development of a new oral drug to treat visceral leishmaniasis
(WorldNews Switzerland)
 


LXE408 is a first-in-class compound, discovered at Novartis with financial support from the Wellcome Trust Novartis is responsible for completing Phase I clinical trials and has committed to maximizing access in endemic countries, once approved DNDi will lead Phase II and III clinical development, starting in India with additional trials planned in East Africa Leishmaniasis, which is transmitted by the sand fly, affects over one billion people; visceral leishmaniasis, the most serious form of the disease, affects an estimated 50 000 to 90 000 people per year Basel, February 25, 2020 - Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development...


 
55 viewsCategory: General > Europe > Switzerland
 
New: Sunrise Family Benefit with up to 50% discount on additional mobile subscriptions
(WorldNews Switzerland)
Schweizer Notfallplan der Credit Suisse von der FINMA genehmigt
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten